XRAYS - Making Sense of Cancer Headlines

FORCE’s eXamining the Relevance of Articles for Young Survivors (XRAYS) program is a reliable resource for breast cancer research-related news and information. XRAYS reviews new breast cancer research, provides plain-language summaries, and rates how the media covered the topic. XRAYS is funded by the CDC.

XRAYS logo and women

Read the topic that we reviewed this week

ARTICLE: The buzz around MonaLisa Touch

XRAYS Rating
XRAYS article

For many young breast cancer survivors and high-risk women, the side effects from early menopause after treatment and surgery can negatively impact their personal lives. This XRAYS looks at one of the many recent media articles on a laser procedure called MonaLisa Touch. The article, "Is Laser Treatment for Vaginal Atrophy Safe?"  was published online in 2017 by FOX News and written by Dr. Manny Alvarez. XRAYS will discuss what this laser procedure actually is and how it may impact a young breast cancer patient’s life after treatment. (1/19/18)

Search for reviews by category, keyword or date or browse our recent articles below

Featured Studies and Articles

XRAYS Rating

STUDY: No new high-risk breast cancer genes here

While some of the inherited causes of breast cancer are known (for example, inherited mutations in genes like BRCA, ATM and PALB2, others remain unidentified. Two recent reports identified 72 DNA changes (also known as “variants” or “SNPs”) that are associated with increased breast cancer risk.  However, unlike mutations in a gene that dramatically increase risk, the majority of these new variants are not located within the portion of DNA that codes for proteins, and they confer only a small increase in risk. Further research is needed on these new variants before they can be used by doctors to assess and manage cancer risk in patients. (1/12/18)

XRAYS Rating

ARTICLE: Coping with the financial burden of breast cancer

U.S. News & World Report recently talked to three breast cancer survivors, including two young women, about how they handled out-of-pocket costs and other medical expenses after their cancer diagnosis. (Posted 1/4/18)

XRAYS Rating

STUDY: Does extended hormonal treatment impact risk of recurrence?

Hormonal therapy significantly reduces the risk of recurrence for women with early-stage estrogen receptor-positive breast cancer. Standard hormonal therapy is given for 5 years; extending that therapy for a longer period offers additional protection but has added side effects.  A new study looked at women who stopped hormonal therapy after 5 years and identified factors that may guide the decision to extend treatment.  (12/21/17)

XRAYS Rating

STUDY: Birth control and breast cancer risk among younger women

On December 7, 2017 the New England Journal of Medicine published results from a study by Lina Mørrch of the University of Copenhagen and colleagues showing that hormonal contraceptives (birth control) increase the risk of breast cancer. The study is unique because it is one of the first to specifically assess the breast cancer risk associated with newer, low-dosage methods of contraception. The large and significant effort analyzed medical data of nearly 1.8 million young women in Denmark on average for over 10.9 years. Results were covered widely in the U.S. by many major media outlets, including the New York Times, USA Today, Forbes and Time.  (12/14/17)

Find older XRAYS studies and articles

By keyword search:

By date range:

By quarterly digest:

FORCE:Facing Our Risk of Cancer Empowered